Background. We evaluated liver transplantation waitlist and posttransplantation outcomes in those aged 18 to 24 years compared with both younger (0-17 years) and older (25-34 years) registrants and recipients. Methods. Using national data from the United Network for Organ Sharing, competing risk, Cox regression and Kaplan-Meier analyses were performed on first-time liver transplant registrants (n = 13 979) and recipients (n = 8718) ages 0 to 34 years between 2002 and 2015. Results. Nonstatus 1A registrants, registrants aged 0 to 17 and 25 to 34 years were less likely to experience dropout from the waiting list compared with those aged 18 to 24 years (adjusted hazard ratio, 0-5 years = 0.36; 6-11 = 0.29; 12-17 = 0.48; 18-24 = 1.00; 25-34 = 0.82). Although there was no difference in risk of graft failure across all age groups, both younger and older age groups had significantly lower risk of posttransplant mortality compared with those aged 18 to 24 years (adjusted hazard ratio, for 0-5 years = 0.53, 6-11 = 0.48, 12-17 = 0.70, 18-24 = 1.00, 25-34 = 0.77). This may be related to lower likelihood of retransplantation after graft failure in those aged 18 to 24 years. Conclusions. This national registry study demonstrates for the first time poorer waitlist and postliver transplant outcomes in young adults ages 18 to 24 years at the time of listing and transplantation compared to older and younger age groups. Given the potential survival benefit in transplanting young adults and the shortage of solid organs for transplant, future studies are critical to identify and target modifiable risk factors to improve waitlist and long-term posttransplant outcomes in 18-to 24-year-old registrants and recipients.
Van Arendonk et al 5 examined current recipient age to investigate the idea of a high-risk age window that all pediatric transplant recipients must eventually traverse on their path to adulthood and found no difference in liver graft failure rates comparing recipients with current age of 17 to 24 years to older and younger age groups. Foster et al 6 reported differing results, describing higher liver graft failure rates in recipients with current age of 21 to 29 years. These studies conflict regarding the potential contribution of agerelated sociobehavioral risk factors to negative posttransplantation outcomes in young adults. In our study, we examine age at the time of listing and liver transplantation, rather than current age, at a juncture where potential interventions may significantly impact waitlist outcomes and posttransplant graft and patient survival.
Differences also remain in the allocation of organs and use of exception scores between and within pediatric and adult populations. Although pediatric and adult registrants of the same medical urgency receive equal priority for livers from adult donors, priority offers are given first to local and regional pediatric registrants when donors are younger than 17 years. 7 Age-related differences also exist in the utilization of nonstandard exception scores in children, where younger children are more likely to be granted these exception scores compared with older children, whereas in adults the majority of exception scores are standard exceptions for hepatocellular carcinoma. 8, 9 Based on previous work regarding sociobehavioral risk factors in young adults and in the context of the existing allocation policy for liver transplant and use of exception scores, we hypothesized that those aged 18 to 24 years will have a lower use of exception scores, higher risk of death or dropout from the waitlist, higher rates of graft attrition and worse posttransplant survival compared to both children (0-17 years) and older adults (25-34 years) . We used national waitlist and transplant data from the United Network for Organ Sharing (UNOS) to compare patients ages 18 to 24 years with both immediately older and younger age groups with respect to: (1) primary indications for liver transplantation; (2) waitlist outcomes including death, dropout, and transplantation; and (3) posttransplantation graft and patient survival.
MATERIALS AND METHODS

Data Source and Study Population
We received data from UNOS on all patients listed for liver transplantation (registrants) and all patients who underwent transplantation (recipients) in the United States from February 27, 2002 , the date of introduction of the Model for End-Stage Liver Disease (MELD) allocation system, to March 31, 2015 . We limited our study to first-time transplant registrants (n = 16,058) and transplant recipients (n = 8,728) aged 0 to 34 years. We excluded registrants who were listed for multiorgan transplants (n = 2,070) or whose MELD score was missing at the time of listing (n = 9), leaving 13 979 transplant registrants in the current analysis. We excluded multiorgan recipients (n = 4) and recipients missing MELD score data (n = 6) at transplant, leaving 8718 recipients in the current analysis. As inferior graft and patient survival outcomes have been reported for both small-for-size syndrome and large-for-size transplant, graft size mismatch was calculated based on previously described formulas for both living and deceased donors. [10] [11] [12] This project was approved by the Veterans Affairs Puget Sound Healthcare System Institutional Review Board.
Age Categories
Liver transplant registrants and recipients were divided into 5 age groups based on age at the time of listing or transplantation, 0 to 5, 6 to 11, 12 to 17, 18 to 24, and 25 to 34 years, respectively. 2, 13 The 0 to 5 years age category was selected based on the Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients annual data report. 13 Additionally, 12 years of age comprises the inflection point when pediatric patients are assigned a MELD, rather than a pediatric end-stage liver disease (PELD) score. For the purposes of this study, it was critical to define a young adult population. We therefore divided the 18 to 34 years age category used in the Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients annual data report and selected 24 years as the upper age limit for this group based on young adult renal transplantation studies and population-based studies, which identify those aged 18 to 24 years as a high-risk age group in the general population. 5, [13] [14] [15] Modeling the Association Between Age and Waitlist Outcomes
We used competing risks analysis to examine the association between age at listing (0-5, 6-11, 12-17, 18-24 years [the reference category] and 25-34 years) and the following 3 waitlist competing outcomes: transplantation, death, or drop out from the waitlist. 16 Dropout was defined as any removal from the waitlist except for registrants removed due to "condition improved," who were censored. Registrants were also censored if they were still alive and awaiting transplantation by the end of the study period on March 31, 2015. 17 The competing risks models included the following registrant characteristics ascertained at the time of listing: sex, race or ethnicity, underlying liver disease, ABO blood group, initial listing year, listing PELD/MELD score, whether an exception score was granted (yes/no variable), serum albumin, and insurance payer status. Additionally, UNOS region was included as a covariate because the competing risks analysis software does not handle strata.
When comparing registrants with the same medical acuity, previous studies have noted differences in waitlist mortality when further stratified by age, particularly when comparing children and adults. 18 We therefore performed clinically relevant subgroup analyses by subdividing transplant registrants based on status 1A or nonstatus 1A priority and by MELD score less than 20 or 20 or greater. Sex inequities have previously been described in adult liver transplant registrants, with women having higher waitlist mortality compared with men. 19 We therefore performed subgroup analyses by sex.
Modeling the Association Between Age and Posttransplantation Graft and Patient Survival
Graft failure was defined as failure leading to either retransplantation or resulting in recipient death. Graft survival time was defined as time from initial transplantation until retransplantation, death or until March 31, 2015, for registrants who were still alive at the end of the study period. Recipient survival time was measured as the number of days from liver transplantation to the date of death; patients who were retransplanted or were still alive at the end of the study period were censored at that time.
We used a Cox proportional hazards regression model stratified by UNOS region to study the association between age at transplantation and posttransplantation graft survival or patient survival with and without adjusting for recipient and donor characteristics. Additional subanalyses examined differences in posttransplantation graft and patient survival by sex and 1A status. Recipient characteristics were the same as those used in waitlist analyses listed above, except they were ascertained at the time of transplantation. The following donor characteristics were included in our models: age, gender, race or ethnicity, body mass index (BMI), ABO match, donor type (living or deceased), cause of donor death, donation after circulatory death, donor organ type, cold ischemia time, and organ location (local, regional, national). Observations were stratified by UNOS region. The assumption of proportional hazards was tested and met using weighted residual methods.
In addition to the proportional hazards analysis, we performed an ordered logistic regression analysis among patients who experienced graft loss to determine whether age was associated with graft failure (0-29 days) 20 versus early graft loss (between 30 and 365 days) versus late graft loss (>365 days). 21 Logistic regression analysis was used to determine if there was an association between age and retransplantation after graft failure.
Analytical Software
Stata MP version 14.1 (64-bit) (College Station, TX) was used for Cox PH analyses and R version 3.2.2 (64-bit) for competing risks analyses. 16, 22 A P value less than 0.05 was considered statistically significant.
RESULTS
Baseline Characteristics of Liver Transplant Registrants and Recipients by Age Group
Baseline characteristics at the time of listing (Table 1) were similar to baseline characteristics at transplantation (Table 2) . Adults aged 18 to 24 years had higher mean calculated MELD scores at listing (23.2 ± 12.2) and transplantation (26.2 ± 11.5) and were less likely to have an exception score granted at any time while on the waitlist (18.1%) compared with children and adolescents (0-17 years). There were no differences in MELD scores at listing or transplantation or in the utilization of exception scores between ages 18 to 24 and 25 to 34 years.
Registrants aged 18 to 24 years were more likely to be listed for acute liver failure (ALF) compared with all other age groups. Among registrants with status 1A priority, those aged 18 to 24 years were also more likely to be removed from the waiting list secondary to improved condition ( Figure 1A ). Despite this, ALF (29.0%) persisted as the highest indication for transplantation in recipients aged 18 to 24 years compared with all other age groups, followed by primary sclerosing cholangitis (PSC) (15.7%) and metabolic liver disease (13.1%) ( Figure 2A , Table 2 ).
Graft size mismatch was uncommon in ages 18 to 24 years with 0% having small-for-size grafts in living donor transplantation. In deceased donor transplantation, those aged 18 to 24 years were least likely to receive a small-for-size graft (4.8%) 
≥35.
c For waiting list analyses, an exception score was only included in the listing PELD/MELD score if an exception was granted within 30 days of listing (10) . If a standard exception or additional exception score was granted at any time while the registrant was on the waitlist, this was categorized as a yes/no variable and reported as the percentage of total registrants within each age subgroup. compared with all other age groups and only 9.2% received a large-for-size graft. Very young children ages 0 to 5 years were much more likely to receive a liver from a live donor (14.7%) or a split liver (21%) compared with all other age groups; by comparison 8.4% of those aged 18 to 24 years received a liver from a live donor and 1.7% received a split liver (Table 2) .
Waitlist Outcomes by Age
Among nonstatus 1A registrants, both younger and older age groups (ages 0
and were more likely to be transplanted compared with 18-to 24-year-old registrants (ASHR: 1.94 for ages 0-5 years, 2.04 for ages 6-11 years, 1.49 for ages 12-17 years, 1.00 for ages 18-24 years, 1.05 for ages 25-34 years), whereas those aged 25 to 34 years had a similar likelihood of the combined outcome of death or dropout from the waiting list or transplantation (Table 3 , Figures 1B and C) . In subanalyses, these associations were strongest in registrants with MELD scores less than 20 [Tables S1a and S1b, SDC, http://links.lww.com/TP/B412]. After adjusting for sex in competing risks analyses examining the association between age at listing and waitlist outcomes in nonstatus 1A registrants, poorer waitlist outcomes for those aged 18 to 24 years persisted (Table 3) . Waitlist time from listing to dropout, death or transplantation was not significantly different between ages 18 and 24 years, adolescents (12-17 years), and older adults (25-34 years) ( Table 1) .
Among status 1A registrants, only those aged 6 to 11 years had a lower waitlist mortality and a higher likelihood of transplantation compared with those aged 18 to 24 years (Table S2 , SDC, http://links.lww.com/TP/B412 and Figure 1A ).
Association Between Age and Posttransplantation Graft Survival
After adjusting for recipient and donor characteristics, recipients aged 18 to 24 years had a similar risk of graft failure compared with all other age groups (Table 4, Figure 2B ). This finding remained unchanged in subgroup analyses of male and female recipients ( Tables S3a and S3b , SDC, http://links.lww.com/TP/B412) and in recipients listed as status 1A or nonstatus 1A (Table S4a and S4b, SDC, http:// links.lww.com/TP/B412).
However, there were important differences in the timing of graft failure and loss by age group. Among recipients with graft failure in the first 0 to 29 days after transplant, this event was more likely to occur in children ages 0 to 11 years with the highest probability in ages 0 to 5 years compared with older age groups (proportion: 0.60 for ages 0-5 years, 0.43 for ages 6-11 years, 0.18 for ages 12-17 years, 0.21 for ages 18-24 years, 0.28 for ages 25-34 years). Among recipients with late graft loss (>365 days after transplantation), this event was more likely to occur in adolescents (ages 12-17 years) and adults (ages 18-24 and 25-34 years) compared with children aged 0 to 11 years Graft weight-to-recipient body weight ratio (GWBWR) < 0.8% where GWBWR = graft weight (kg) / recipient body weight (kg).
30,31
b BSA index (BSAi) < 0.78 where BSAi = BSA donor / BSA recipient.
30,32
c BSAi > 1.24.
DCD, donation after cardiac death.
(proportion: 0.23 for ages 0-5 years, 0.36 for ages 6-11 years, 0.67 for ages 12-17 years, 0.62 for ages 18-24 years, 0.53 for ages 25-34 years). There was no difference in the probability of early graft loss (30-365 days after transplant) across age groups (Table S5 , SDC, http://links.lww.com/TP/B412).
Association Between Age and Posttransplantation Patient Survival
Children and adolescents (0-17 years) and adults aged 25 to 34 years had significantly lower posttransplant mortality compared with those aged 18 to 24 years (AHR: 0.53 for ages 0-5 years, 0.48 for ages 6-11 years, 0.70 for ages 12-17 years, 1.00 for ages 18-24 years, and 0.77 for ages 25-34 years) after adjusting for a large number of recipient and donor characteristics. The probability of survival at 1, 2, and 5 years posttransplant was the lowest for recipients aged 18 to 24 years at 0.91, 0.88, and 0.79, respectively, compared with all other age groups (Table 5, Figure 2C ). These associations between-age groups and posttransplantation survival were very similar in male and female subgroups ( Tables S6a and  S6b , SDC, http://links.lww.com/TP/B412). In subanalyses by medical acuity, these associations were strongest in recipients transplanted as nonstatus 1A (AHR: 0.55 for ages 0-5 years, 0.45 for ages 6-11 years, 0.68 for ages 12-17 years, 1.00 for ages 18-24 years, and 0.74 for ages 25-34 years) ( Tables S7a and S7b , SDC, http://links.lww. com/TP/B412).
Retransplantation after graft failure occurred more commonly in ages 0 to 5 years (76%; odds ratio [OR], 2.53), 6 to 11 years (78%; OR, 2.78), and 12 to 17 years (72%; OR, 2.00) compared with ages 18 to 24 years (56%; OR, 1.00), whereas ages 25 to 34 years had a similar likelihood of retransplantation after graft failure (63%; OR, 1.34) ( Table 6 ). In subanalyses by acuity, this association was strongest in recipients transplanted as nonstatus 1A (Tables S8a and S8b , SDC, http://links.lww.com/TP/B412). Death after graft failure was also significantly more common in ages 18 to 24 years (43%) compared with ages 0 to 5 years (21%), 6 to 11 years (18%), 12 to 17 years (28%), and 25 to 34 years (37%) (χ 2, , P < 0.001). Subanalyses by sex noted a strikingly higher percentage of women ages 18 to 24 years dying after graft failure (48.9%) than men (37.1%). Women aged 0 to 17 and 25 to 34 years were also more likely to be retransplanted compared with women aged 18 to 24 years, whereas in men, there was no difference in the odds of retransplantation across all age groups ( Table S9a and S9b, SDC, http://links. lww.com/TP/B412).
DISCUSSION
This analysis of national registry data demonstrates worse waitlist and posttransplant outcomes in ages 18 to 24 years compared with both younger and older age groups among liver transplant registrants and recipients in the United States from 2002 to 2015. Notably, recipients aged 18 to 24 years had the highest mortality after transplant with a 5-year posttransplant survival probability of 0.79. Among non-status 1A registrants, ages 18 to 24 years were more likely to experience drop out from the waitlist. Although there was no difference in graft failure across age groups, FIGURE 1. Waitlist outcomes by age group for status 1A and nonstatus 1A registrants. A, Among status 1A registrants, ages 6 to 11 years had the lower waitlist mortality and a higher likelihood of transplantation compared with those aged 18 to 24 years. B, Among nonstatus 1A registrants, those aged 18 to 24 years had the highest rate of dropout and the lowest rate of transplantation. Dropout was defined as any removal from the waitlist except for registrants removed due to "condition improved," who were censored. C, In multivariate analyses adjusted for baseline characteristics, those aged 18 to 24 years had the highest risk of death or dropout and the lowest likelihood of transplantation.
those aged 18 to 24 years were more likely to have late graft loss, were less likely to be retransplanted, and were more likely to have the outcome of death secondary to graft failure. To our knowledge, this is the first study to examine and demonstrate both poor waitlist and postliver transplant outcomes in the population of young adults aged 18 to 24 years at the time of listing and transplantation.
ALF was the leading indication for liver transplant in 18-to 24-year-old registrants and recipients. Not surprisingly, given the priority allocated to critically ill status 1A registrants, there were few differences in waitlist outcomes when comparing both younger and older age groups with 18-to 24-year-old registrants.
Among nonstatus 1A registrants, those aged 0 to 17 and 25 to 34 years had a significantly lower risk of waitlist dropout compared with those aged 18 to 24 years, and these associations were strongest in those with MELD scores less than 20. Hsu et al previously demonstrated that younger children are more likely to be granted exception scores compared with older children. 8 Additional studies have also found that children and adults who are granted nonstandard exception scores have decreased waitlist mortality and are more likely to be transplanted compared with registrants without nonstandard exception requests. 23, 24 In support of these trends, we found that adults aged 18 to 24 years were significantly less likely to be granted an exception score at any time while on the waiting list, had lower MELD exception scores compared with those aged 0 to 17 years and had poorer waitlist outcomes despite having the highest mean calculated MELD score at listing and transplantation. In our study, although the primary indications for liver transplantation were similar between ages 12 to 17 years and 18 to 24 years, the decline in the use of exception scores at the transition between adolescence and adulthood was dramatic. This likely reflects a culture of advocacy for children by providers most attuned to the utilization of nonstandardized exception scores in the youngest registrants with significant implications on waitlist outcomes.
In the process of transition from late adolescence to adulthood, 18 to 24 years age out of potential allocation benefits allotted to the pediatric population where children with similar medical urgency to adult registrants receive equal priority for adult organs while also retaining priority offers from pediatric donors. 7 We found that younger children were more likely to receive split livers or livers from living donors compared with young adults, further expanding the donor pool for children in a time of organ scarcity. The advantage of 1B status additionally applies only to pediatric registrants younger than 18 years with chronic liver disease who meet specific criterion, whereas the adult equivalent of status 2A was eliminated in 2002. 25 Moreover, children with metabolic liver disease causing hyperammonemia may be advanced to 1B status after 30 days; this same advantage is not conferred to those aged 18 to 24 years in whom the third leading indication for liver transplantation is metabolic liver disease. 26 As those aged 18 to 24 years age out of the allocation benefits FIGURE 2. Primary indications for liver transplantation and posttransplant graft and patient survival by age at transplant. A, Indications for liver transplantation by age are presented as a 100% stacked area graph, showing dramatic changes by age. In registrants aged 18 to 24 years, acute hepatic necrosis (29.0%) was the most common indication for transplantation followed by PSC (15.7%) and metabolic liver disease (13.1%). B, Kaplan-Meier curves show lower observed graft survival in 18-24 year olds than in other age groups. (However, after adjusting for recipient and donor characteristics, recipients aged 18 to 24 years had a similar risk of graft failure compared to all other age groups). C, Kaplan-Meier curves show lower observed patient survival in those aged 18 to 24 years than in other age groups (also confirmed in multivariate Cox proportional hazards analysis).
allotted to the pediatric population, we found they are also disadvantaged by a lower utilization of exception scores with higher rates of waitlist dropout and lower rates of transplantation.
There was no difference in the risk of graft failure for recipients aged 18 to 24 years at the time of transplant compared with all other age groups. Among those with graft failure, 18-to 24-year-old recipients along with adolescents and older adults were more likely to have late graft loss, compared with children aged 0 to 11 years. Previous studies in children have noted that acute and chronic rejection account for up to 48% of late graft loss, whereas hepatic artery thrombosis and biliary strictures combined account for an additional 20% of late graft loss in children. 20, 21 In adults, recurrent disease and chronic rejection primarily account for hepatic causes of late graft loss. 27 Immunosuppression nonadherence has been well documented in young adults across all solid organ transplants and may be one potential contributor to late graft loss in this population. Novel solutions continue to target the transition between pediatric and adult care with the aim to decrease chronic rejection leading to retransplantation or death. 2, 4, 28, 29 Most strikingly, we found that adults aged 18 to 24 years had higher posttransplant mortality and a lower probability of survival at 1, 2, and 5 years posttransplant compared with both younger and older age groups. Although previous studies have found higher posttransplantation mortality in both adult female recipients 19 and adults transplanted for ALF due to suicide, trauma, or immunosuppression nonadherence, 30 higher posttransplant mortality in those aged 18 to 24 years persisted in our study even after adjusting for sex and 1A status.
Insights into potential causes of higher posttransplant mortality were obtained from subgroup analyses of recipients with graft failure. Overall, recipients aged 18 to 24 years with death secondary to graft failure comprised a large proportion of total deaths in this age category (38%). Recipients aged 18 to 24 years with graft failure were less likely to be retransplanted and had the highest proportion of deaths secondary to graft failure compared with all other age groups, with female recipients accounting primarily for these differences. Sex disparities in posttransplantation outcomes for adult women have previously been described with potential etiologies including poorer graft survival due to lower-quality grafts for women compared with men and a higher risk of posttransplantation renal impairment in females; though these variables were not available for analysis in our study. 31 One limitation of our analyses is that specific causes of graft failure, death and the capture of sociobehavioral risk factors cannot be further delineated due to the high degree of missing data of these variables in UNOS. This is a known limitation of using a large national database where data cannot be further verified and missing data cannot be retrieved. These limitations, however, are balanced by the strengths of using a large transplant data set, which enhances study power and the ability to detect meaningful differences while also increasing generalizability through utilization of a national registry.
We describe for the first time worse waitlist and posttransplantation outcomes in ages 18 to 24 years compared with both older and younger age groups. At a time of organ scarcity and in a population of young adults in whom survival benefit is significant, 32 future single or multicenter studies are needed to delineate the potential contribution of sociobehavioral risk factors on posttransplantation outcomes, specific causes of graft failure and barriers to retransplantation to target interventions and maximize ideal long-term outcomes in young adults aged 18 to 24 years. Finally, the lower utilization of nonstandard exception scores in young adults compared with older adolescents is stark, and future collaborative work across the pediatric and adult transplant communities are needed to ensure parity in our allocation system. 
